Related Experiment Video
Updated: Jan 19, 2026

09:49
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
3.9K
Comparative analysis of penile implants in patients with vasculogenic erectile dysfunction versus postradical
R Cocera1, J Torremade2, J F Suarez1
1Department of Urology and Renal Transplantation, Bellvitge University Hospital, IDIBELL, Barcelona, Spain.
International Journal of Impotence Research
|September 26, 2019
Summary
Penile prosthesis implantation for erectile dysfunction (ED) after radical prostatectomy (PRP) resulted in shorter cylinder lengths compared to vasculogenic ED. Postoperative outcomes were similar between the two groups.
Area of Science:
- Urology
- Andrology
- Surgical Outcomes
Background:
- Penile prosthesis implantation is a primary treatment for erectile dysfunction (ED) unresponsive to medical therapies.
- Vasculogenic ED and ED following radical prostatectomy (PRP) are the leading causes for prosthesis implantation.
- Limited comparative data exists on surgical outcomes between these two primary ED etiologies.
Purpose of the Study:
- To compare surgical outcomes of penile prosthesis placement in patients with severe erectile dysfunction due to vasculogenic causes versus those who underwent radical prostatectomy.
- To identify differences in patient demographics, comorbidities, surgical factors, and postoperative complications between the two groups.
Main Methods:
- A retrospective analysis of 117 primary penile prosthesis implantations (58 for PRP, 59 for vasculogenic ED).
- Data collected included patient age, comorbidities, prosthesis type, cavernous fibrosis, need for modeling, implanted cylinder size, and intra/postoperative complications.
- Statistical analysis was performed to compare outcomes between the PRP and vasculogenic ED groups.
Main Results:
- Vasculogenic ED patients had higher rates of hypertension, diabetes, dyslipidemia, and ischemic heart disease.
- No significant differences were found in cavernous fibrosis or the need for modeling maneuvers.
- Patients with ED post-PRP received significantly shorter implanted cylinders (18.30 cm) compared to those with vasculogenic ED (19.21 cm).
Conclusions:
- Penile prosthesis implantation for ED following PRP is associated with the need for shorter cylinder lengths compared to vasculogenic ED.
- Despite a trend towards more modeling in the PRP group, postoperative outcomes such as infection and mechanical failure rates were comparable between the two groups.
Related Concept Videos
Disorders of the Male Reproductive System
4.0K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
4.0K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
571
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
571

